0001652917-16-000011.txt : 20160519
0001652917-16-000011.hdr.sgml : 20160519
20160519162635
ACCESSION NUMBER: 0001652917-16-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160517
FILED AS OF DATE: 20160519
DATE AS OF CHANGE: 20160519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9143477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van Plew Daniel P
CENTRAL INDEX KEY: 0001411984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 161663482
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-05-17
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001411984
Van Plew Daniel P
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP & General Mgr Industrial O
Common Stock
2016-05-17
4
M
0
9460.0
30.63
A
11381
D
Common Stock
2016-05-17
4
F
0
746.0
388.14
D
10635
D
Common Stock
2016-05-17
4
F
0
4301.0
388.14
D
6334
D
Common Stock
2016-05-18
4
S
0
4413.0
385.77
D
1921
D
Common Stock
18705
I
by GRAT
Common Stock
1444
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
30.63
2016-05-17
4
M
0
9460.0
0.0
D
2020-12-14
Common Stock
9460
32735
D
Represents volume-weighted average price of sales of 4,413 shares of Company stock on May 18, 2016 at prices ranging from $385.66 to $385.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 18, 2016 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.
/s/**Daniel P. Van Plew
2016-05-19